Literature DB >> 18399692

Structural complexes of human adenine phosphoribosyltransferase reveal novel features of the APRT catalytic mechanism.

Carlos H T P Silva1, Mario Silva, Jorge Iulek, Otavio H Thiemann.   

Abstract

Adenine phosphoribosyltransferase (APRT) is an important enzyme component of the purine recycling pathway. Parasitic protozoa of the order Kinetoplastida are unable to synthesize purines de novo and use the salvage pathway for the synthesis of purine bases rendering this biosynthetic pathway an attractive target for antiparasitic drug design. The recombinant human adenine phosphoribosyltransferase (hAPRT) structure was resolved in the presence of AMP in the active site to 1.76 A resolution and with the substrates PRPP and adenine simultaneously bound to the catalytic site to 1.83 A resolution. An additional structure was solved containing one subunit of the dimer in the apo-form to 2.10 A resolution. Comparisons of these three hAPRT structures with other 'type I' PRTases revealed several important features of this class of enzymes. Our data indicate that the flexible loop structure adopts an open conformation before and after binding of both substrates adenine and PRPP. Comparative analyses presented here provide structural evidence to propose the role of Glu104 as the residue that abstracts the proton of adenine N9 atom before its nucleophilic attack on the PRPP anomeric carbon. This work leads to new insights to the understanding of the APRT catalytic mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18399692     DOI: 10.1080/07391102.2008.10507205

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  6 in total

1.  Structural basis for substrate selectivity and nucleophilic substitution mechanisms in human adenine phosphoribosyltransferase catalyzed reaction.

Authors:  Mohammad Ozeir; Jessica Huyet; Marie-Claude Burgevin; Benoît Pinson; Françoise Chesney; Jean-Marc Remy; Abdul Rauf Siddiqi; Roland Lupoli; Grégory Pinon; Christelle Saint-Marc; Jean-François Gibert; Renaud Morales; Irène Ceballos-Picot; Robert Barouki; Bertrand Daignan-Fornier; Anne Olivier-Bandini; Franck Augé; Pierre Nioche
Journal:  J Biol Chem       Date:  2019-06-03       Impact factor: 5.157

Review 2.  Phosphoribosyl Diphosphate (PRPP): Biosynthesis, Enzymology, Utilization, and Metabolic Significance.

Authors:  Bjarne Hove-Jensen; Kasper R Andersen; Mogens Kilstrup; Jan Martinussen; Robert L Switzer; Martin Willemoës
Journal:  Microbiol Mol Biol Rev       Date:  2016-12-28       Impact factor: 11.056

3.  Transcriptome and metabolome analysis of crGART, a novel cell model of de novo purine synthesis deficiency: Alterations in CD36 expression and activity.

Authors:  Randall C Mazzarino; Veronika Baresova; Marie Zikánová; Nathan Duval; Terry G Wilkinson; David Patterson; Guido N Vacano
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

Review 4.  From purines to purinergic signalling: molecular functions and human diseases.

Authors:  Zhao Huang; Na Xie; Peter Illes; Francesco Di Virgilio; Henning Ulrich; Alexey Semyanov; Alexei Verkhratsky; Beata Sperlagh; Shu-Guang Yu; Canhua Huang; Yong Tang
Journal:  Signal Transduct Target Ther       Date:  2021-04-28

5.  Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson's disease.

Authors:  Mihaela Ileana Ionescu
Journal:  ADMET DMPK       Date:  2020-06-15

6.  The CRISPR-Cas9 crATIC HeLa transcriptome: Characterization of a novel cellular model of ATIC deficiency and ZMP accumulation.

Authors:  Randall C Mazzarino; Veronika Baresova; Marie Zikánová; Nathan Duval; Terry G Wilkinson; David Patterson; Guido N Vacano
Journal:  Mol Genet Metab Rep       Date:  2020-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.